- $13.95m
- -$8.63m
- $41.10m
- 24
- 68
- 41
- 41
Annual income statement for Equillium, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 15.8 | 36.1 | 41.1 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 29.5 | 37.8 | 77.8 | 50.6 | 49.4 |
| Operating Profit | -29.5 | -37.8 | -62.1 | -14.5 | -8.27 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -29.8 | -39.1 | -62.4 | -12.8 | -7.71 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -29.8 | -39.1 | -62.4 | -13.3 | -8.07 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -29.8 | -39.1 | -62.4 | -13.3 | -8.07 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -29.8 | -39.1 | -62.4 | -13.3 | -8.07 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.52 | -1.36 | -1.84 | -0.384 | -0.228 |